secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001104659-24-130805
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aeon Biopharma reduces shareholder quorum requirement to 33.34%
---------------------------------------------------------------

- Quorum for shareholder meetings changed from a majority to 33.34% of outstanding voting power.
- Amendment to Bylaws adopted on December 18, 2024, effective immediately.
- Certificate of Amendment filed as Exhibit 3.1 with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000110465924130805/0001104659-24-130805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000110465924130805/tm2431750d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-130805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer